Inspire Medical Investors Face Jan. 5 Deadline in Suit Over Inspire V Rollout Claims

Overview

• The putative securities class action, captioned City of Pontiac Reestablished General Employees' Retirement System v. Inspire Medical Systems, Inc., is pending in the U.S. District Court for the District of Minnesota and covers purchases from August 6, 2024 to August 4, 2025.
• Filings cite a Medicare claims software update that did not take effect until July 1, 2025, which allegedly prevented billing for Inspire V procedures during the early rollout.
• Complaints allege many implanting centers had not completed required training, contracting, and onboarding to begin using the new device.
• Plaintiffs claim providers held surplus inventory of the older Inspire IV system, which they say weakened demand for Inspire V.
• On August 4, 2025, Inspire cut 2025 EPS guidance by more than 80% and shares fell about 32% in one day, and national firms are urging investors to seek lead-plaintiff status by January 5, 2026, with whistleblowers encouraged under the SEC program.